Sign Up for a Free Account
  • Updated 03.03.2020
  • Released 12.27.1996
  • Expires For CME 03.03.2023

Radiation myelopathy

Introduction

Overview

Radiation myelopathy is a relatively rare, but potentially devastating, complication of therapeutic irradiation. As systemic treatments improve and patients live longer with cancer, the incidence of spinal metastases (cord, CSF, dural, epidural) will continue to increase and necessitate the application of palliative radiation, stereotactic body radiotherapy (SBRT), and re-irradiation to the spinal cord. Therefore, the incidence of radiation myelopathy will likely increase, and recognition of the subacute and chronic progressive forms of radiation myelopathy will become critical to distinguish from recurrent tumor and permit early intervention. The authors summarize the clinical features, pathophysiology, and management issues for patients with radiation myelopathy.

Key points

• Radiation myelopathy is a rare complication of modern therapeutic radiation.

• The generally accepted dose and fractionation parameters predicting the risk of radiation myelopathy may not necessarily apply to patients who receive a second course of radiation, concurrent radiation plus chemotherapy, or spinal stereotactic radiosurgery.

• Most patients with chronic progressive radiation myelopathy are permanently neurologically disabled; there is no proven effective therapy.

Historical note and terminology

Spinal cord injury following therapeutic radiation was first recognized in the mid-1940s, shortly after the introduction of megavoltage radiotherapy (04; 31). The term "radiation myelopathy" encompasses at least three distinct clinicopathologic entities: (1) a common, but mild subacute (transient) myelopathy, (2) a less common, but catastrophic chronic progressive (delayed) myelopathy, and (3) an unusual selective lower motor neuron syndrome. Therapeutic radiation has also been implicated in spinal cord hemorrhage, the induction of spinal cord neoplasms, and development of vascular malformations.

Start a MedLink Neurology trial
to unlock 3 free articles.

  • Nearly 3,000 illustrations, 
including video clips of 
neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of 
neurology in 1,200 
comprehensive articles.

Questions or Comment?

MedLink, LLC

10393 San Diego Mission Rd, Suite 120

San Diego, CA 92108-2134

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com